Preliminary Programmes
Saturday 11 February 2017
Loewenthal Auditorium, Westmead Education Centre
1. Clinical & Scientific Programme
The clinical and scientific programme is aimed at providing practical updates on diagnosis and management (including major advances in disease-modifying treatment) of each of the major amyloidosis disorders, predominantly AL, AA and ATTR – familial and wild type.
Recent advances are particularly relevant to cardiologists but also of importance to clinicians across all of the fields affected by amyloid disease
Plenary Session 1 Advances in diagnosis 8.30-10.20am
Chair : Graeme Stewart
8.30am Introduction and Welcome
8.40am What is amyloidosis ?
Peter Mollee
8.50am The spectrum and prevalence of the amyloid diseases
Fiona Kwok
9.00am How to diagnose and type amyloidosis
Philip Hawkins
9.40am How to diagnose cardiac amyloidosis
Rodney Falk
10.20 – 10.50am COFFEE BREAK
Plenary Session 2 Brief updates 10.50am – 12.20pm
Chair : Fiona Kwok
10.50am Amyloid L disease
Simon Gibbs
11.00am Autoinflammation and Amyloid A disease
Ming-Wei Lin
11.10am Detection of amyloidogenic genetic mutations
David Booth
11.20 amFamilial amyloidosis : carrier detection and prophylaxis
Graeme Stewart
11.30am Amyloid neuropathies
Steve Vucic
12.00pm Renal amyloidosis
Richard Phoon
12.10pm Cardiac amyloidosis : the Westmead experience
Liza Thomas
12.20 – 1.00pm LUNCH
Plenary Session 3 Advances in management 1.00 – 2.20pm
Chair : Peter Mollee
1.00pm Cardiac amyloidosis
Rodney Falk
1.40pm Non-cardiac amyloidosis
Philip Hawkins
Parallel Session 1 Cardiac Amyloidosis 2.30 – 3.40pm
Case-based interactive session with Rodney Falk
Chair : Liza Thomas
Designed to assist specialists involved in the diagnosis and management of cardiac amyloidosis in understanding the varied clinical presentations and in meeting the diagnostic and treatment challenges in 2017.
2.30 – 3.30pmSix selected case presentations and discussions aimed at
highlighting the many difficulties and traps encountered
in the specialised amyloidosis centres
3.30 – 3.40pmSummary and final questions
Philip Hawkins
Parallel Session 2 Non-cardiac Amyloidosis 2.30 – 2.30pm
Case-based interactive session with Philip Hawkins
Chair : Ming-Wei Lin
Designed to assist specialists in Tissue Pathology, Medical Imaging (MRI, Nuclear Medicine, PET), Haematology, Rheumatology, Immunology, Genetic Medicine, Neurology and Renal Medicine in understanding the varied clinical presentation and prevalence and in meeting the diagnostic and treatment challenges in the range of amyloidosis disorders in 2017.
2.30 – 3.30pm Case presentations and discussions selected to highlight
the many difficulties and traps encountered in the specialised
amyloidosis centres
3.30 – 3.40pmSummary and final questions
Philip Hawkins
3.40 – 4.10pm COFFEE BREAK
Plenary Session 4 Future directions 4.10 – 4.50pm
Chair : Simon Gibbs
4.10 – 4.30pm How close is a cure for amyloidosis ? Scientific breakthrough
and planned clinical trials
Philip Hawkins
4.30-4.50pm Final questions and discussion
Philip Hawkins and Rodney Falk
4.50pm WORKSHOP CLOSE